目次

TABLE OF CONTENT

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 KEY INCLUSIONS & EXCLUSIONS
1.3 RESEARCH SCOPE
1.3.1 SEGMENTS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 MAJOR MARKET STAKEHOLDERS
1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA SOURCES
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.3 MARKET SHARE ESTIMATION METHODOLOGY
2.4 MARKET BREAK DOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 SCOPE RELATED LIMITATIONS
2.6.2 METHODOLOGY RELATED LIMITATIONS
2.7 RISK ASSESSMENT
2.8 RECESSION IMPACT ASSESSMENT APPROACH

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 MAJOR DRIVERS
5.1.2 KEY RESTRAINTS
5.1.3 KEY GROWTH OPPORTUNITIES
5.1.4 INDUSTRY-SPECIFIC CHALLENGES
5.2 REGULATORY LANDSCAPE
5.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.2.2 REGULATORY ANALYSIS
5.3 VALUE CHAIN ANALYSIS
5.4 SUPPLY CHAIN ANALYSIS
5.5 ECOSYSTEM MARKET MAP
5.6 TECHNOLOGY ANALYSIS
5.7 TRADE DATA ANALYSIS
5.8 PATENT ANALYSIS
5.9 PORTER’S FIVE FORCE ANALYSIS
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE OF KEY PLAYERS BY PRODUCT
5.10.2 AVERAGE SELLING PRICE TRENDS
5.11 KEY CONFERENCES AND EVENTS IN 2022-23
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.2 BUYING CRITERIA

6 NEAR INFRARED IMAGING MARKET, BY PRODUCT TYPE (USD MILLION; 2021—2028)*
6.1 DEVICES
6.1.1 FLUORESCENCE IMAGING SYSTEMS
6.1.2 FLUORESCENCE AND BIOLUMINESCENCE IMAGING SYSTEMS
6.2 NIR IMAGING AGENTS/PROBES
6.2.1 INDOCYANINE GREEN
6.2.2 OTHER REAGENTS
6.3 NIR DYES
6.3.1 ORGANIC DYES
6.3.2 NANOPARTICLE DYES

7 NEAR INFRARED IMAGING MARKET, BY APPLICATION (USD MILLION; 2021—2028)*
7.1 PRECLINICAL IMAGING
7.2 CLINICAL IMAGING
7.3 MEDICAL IMAGING

8 NEAR INFRARED IMAGING MARKET, BY PROCEDURE (USD MILLION; 2021—2028)*
8.1 CANCER SURGERIES
8.1.1 BRAIN CANCER/TUMOR SURGERIES
8.1.2 OTHER CANCER SURGERIES
8.2 GIT SURGERIES
8.2.1 COLORECTAL SURGERIES
8.2.2 OTHER GIT SURGERIES
8.3 CARDIOVASCULAR SURGERIES
8.4 PLASTIC/RECONSTRUCTIVE SURGERIES
8.5 OB/GYN SURGERIES

9 NEAR INFRARED IMAGING MARKET, BY END-USER (USD MILLION; 2021—2028)*
9.1 HOSPITALS AND SURGICAL CLINICS
9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.3 RESEARCH LABS AND ACADEMIC INSTITUTES
9.4 OTHER END USERS

10 NEAR INFRARED IMAGING MARKET, BY REGION (USD MILLION; 2021—2028)*
10.1 NORTH AMERICA
10.1.1 US
10.1.2 CANADA
10.2 EUROPE
10.2.1 GERMANY
10.2.2 UK
10.2.3 FRANCE
10.2.4 ITALY
10.2.5 SPAIN
10.2.6 REST OF EUROPE
10.3 ASIA-PACIFIC
10.3.1 JAPAN
10.3.2 CHINA
10.3.3 INDIA
10.3.4 SOUTH KOREA
10.3.5 AUSTRALIA
10.3.6 REST OF ASIA-PACIFIC
10.4 LATIN AMERICA
10.4.1 BRAZIL
10.4.2 MEXICO
10.4.3 REST OF LATIN AMERICA
10.5 MIDDLE EAST AND AFRICA

11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 REVENUE SHARE ANALYSIS OF KEY PLAYERS (2022)
11.3 MARKET SHARE ANALYSIS FOR TOP 3 - 5 GLOBAL PLAYERS (IN TERMS OF %REVENUE, IN 2022)
11.4 COMPANY FOOTPRINT ANALYSIS
11.5 COMPETITIVE BENCHMARKING
11.6 COMPETITIVE SITUATION AND TRENDS (2021-2023)
11.6.1 PRODUCT LAUNCHES AND APPROVALS
11.6.2 DEALS
11.7 COMPANY EVALUATION QUADRANT
11.7.1 PERVASIVE PLAYERS
11.7.2 EMERGING LEADERS
11.7.3 PARTICIPANTS
11.7.4 STARS

12 COMPANY PROFILES**
(Business Overview, Products Offered, Industry-specific Developments for 2021-2023)***
11.1 BIOSPACE LAB
11.2 CARL ZEISS MEDITECH AG
11.3 FLUOPTICS
11.4 HAMAMATSU PHOTONICS KK
11.5 KARL STORZ SE & CO KG
11.6 LEICA MICROSYSTEMS
11.7 LI-COR INC
11.8 MEDTRONIC PLC
11.9 MIZUHO MEDICAL CO LTD
11.10 OLYMPUS CORPORATION
11.11 PERKINELMER INC
11.12 QUEST MEDICAL IMAGING BV
11.13 SHIMADZU CORPORATION
11.14 STRYKER CORPORATION
11.15 SURGVISION

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS